- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
Patent holdings for IPC class A61K 31/137
Total number of patents in this class: 4650
10-year publication summary
|
399
|
375
|
371
|
401
|
404
|
429
|
411
|
372
|
350
|
204
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 339 |
190 |
| Novartis AG | 10726 |
56 |
| The Regents of the University of California | 20035 |
51 |
| Grünenthal GmbH | 566 |
42 |
| Zogenix International Limited | 76 |
42 |
| Nalpropion Pharmaceuticals LLC | 73 |
39 |
| The Procter & Gamble Company | 22011 |
38 |
| Axsome Therapeutics, Inc. | 261 |
33 |
| Noven Pharmaceuticals, Inc. | 103 |
30 |
| Nevakar Injectables Inc. | 43 |
29 |
| Gruenenthal GmbH | 106 |
27 |
| Aquestive Therapeutics, Inc. | 182 |
25 |
| Pharnext | 91 |
23 |
| The Trustees of Columbia University in the City of New York | 3584 |
22 |
| Radius Pharmaceuticals, Inc. | 50 |
22 |
| Duke University | 3084 |
20 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2866 |
20 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2880 |
19 |
| Ironshore Pharmaceuticals & Development, Inc. | 36 |
19 |
| Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 217 |
18 |
| Other owners | 3885 |